Doxycycline Effects on Serum Bone Biomarkers in Post-menopausal Women

Overview

Journal J Dent Res

Specialty Dentistry

Date 2010 Mar 30

PMID 20348487

Citations 14

Authors

L M Golub

H-M Lee

J A Stoner

R A Reinhardt

T Sorsa

A D Goren

J B Payne

Affiliations

Soon will be listed here.

Abstract

We previously demonstrated that subantimicrobial-dose-doxycycline (SDD) treatment of post-menopausal osteopenic women significantly reduced periodontal disease progression, and biomarkers of collagen destruction and bone resorption locally in periodontal pockets, in a double-blind placebo-controlled clinical trial. We now hypothesize that SDD may also improve biomarkers of bone loss systemically in the same women, consistent with previous studies on tetracyclines (e.g., doxycycline) in organ culture and animal models of bone-deficiency disease. 128 post-menopausal osteopenic women with chronic periodontitis randomly received SDD or placebo tablets daily for 2 years adjunctive to periodontal maintenance therapy every 3-4 months. Blood was collected at baseline and at one- and two-year appointments, and sera were analyzed for bone resorption and bone formation/turnover biomarkers. In subsets of the study population, adjunctive SDD significantly reduced serum biomarkers of bone resorption (biomarkers of bone formation were unaffected), consistent with reduced risk of future systemic bone loss in these post-menopausal women not yet on anti-osteoporotic drugs.

Citing Articles

MicroRNA-101a enhances trabecular bone accrual in male mice.

Dudakovic A, Jerez S, Deosthale P, Denbeigh J, Paradise C, Gluscevic M Sci Rep. 2022; 12(1):13361.

PMID: 35922466 PMC: 9349183. DOI: 10.1038/s41598-022-17579-0.

The effect of choline-stabilized orthosilicic acid in patients with peri-implantitis: an exploratory randomized, double-blind, placebo controlled study.

Teughels W, Celik G, Tarce M, De Cock I, Persyn S, Haytac M BMC Oral Health. 2021; 21(1):485.

PMID: 34587941 PMC: 8480141. DOI: 10.1186/s12903-021-01817-4.

Periodontal therapeutics: Current host-modulation agents and future directions.

Golub L, Lee H Periodontol 2000. 2019; 82(1):186-204.

PMID: 31850625 PMC: 6973248. DOI: 10.1111/prd.12315.

Doxycycline reduces osteopenia in female rats.

de Figueiredo F, Shimano R, Ervolino E, Pitol D, Gerlach R, Issa J Sci Rep. 2019; 9(1):15316.

PMID: 31653893 PMC: 6814740. DOI: 10.1038/s41598-019-51702-y.

Loss of alveolar bone density in postmenopausal, osteopenic women is associated with circulating levels of gelatinases.

Thompson D, Lee H, Stoner J, Golub L, Nummikoski P, Payne J J Periodontal Res. 2019; 54(5):525-532.

PMID: 31032961 PMC: 6776678. DOI: 10.1111/jre.12656.

References

Golub L, Ramamurthy N, McNamara T, Gomes B, Wolff M, Casino A . Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease. J Periodontal Res. 1984; 19(6):651-5. DOI: 10.1111/j.1600-0765.1984.tb01334.x. View

Mohammad A, Preshaw P, Bradshaw M, Hefti A, Powala C, Romanowicz M . Adjunctive subantimicrobial dose doxycycline in the management of institutionalised geriatric patients with chronic periodontitis. Gerodontology. 2005; 22(1):37-43. DOI: 10.1111/j.1741-2358.2004.00044.x. View

Golub L, Lee H, Ryan M, Giannobile W, Payne J, Sorsa T . Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res. 1999; 12(2):12-26. DOI: 10.1177/08959374980120010501. View

Walker C, Puumala S, Golub L, Stoner J, Reinhardt R, Lee H . Subantimicrobial dose doxycycline effects on osteopenic bone loss: microbiologic results. J Periodontol. 2007; 78(8):1590-601. PMC: 2041927. DOI: 10.1902/jop.2007.070015. View

Golub L, Lee H, Greenwald R, Ryan M, Sorsa T, Salo T . A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res. 1997; 46(8):310-9. DOI: 10.1007/s000110050193. View

Looker A, Bauer D, Chesnut 3rd C, Gundberg C, Hochberg M, Klee G . Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int. 2000; 11(6):467-80. DOI: 10.1007/s001980070088. View

Preshaw P, Hefti A, Bradshaw M . Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontol. 2005; 32(6):610-6. DOI: 10.1111/j.1600-051X.2005.00728.x. View

Liu Y, Ramamurthy N, Marecek J, Lee H, Chen J, Ryan M . The lipophilicity, pharmacokinetics, and cellular uptake of different chemically-modified tetracyclines (CMTs). Curr Med Chem. 2001; 8(3):243-52. DOI: 10.2174/0929867013373525. View

Heaney R, Recker R, SAVILLE P . Menopausal changes in bone remodeling. J Lab Clin Med. 1978; 92(6):964-70. View

10.

Zernicke R, Wohl G, Greenwald R, Moak S, Leng W, Golub L . Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis. J Rheumatol. 1997; 24(7):1324-31. View

11.

Bain S, Ramamurthy N, Impeduglia T, Scolman S, Golub L, Rubin C . Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats. Bone. 1997; 21(2):147-53. DOI: 10.1016/s8756-3282(97)00104-x. View

12.

Tuter G, Kurtis B, Serdar M, Aykan T, Okyay K, Yucel A . Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease. J Clin Periodontol. 2007; 34(8):673-81. DOI: 10.1111/j.1600-051X.2007.01104.x. View

13.

Golub L, Ramamurthy N, Llavaneras A, Ryan M, Lee H, Liu Y . A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats. Ann N Y Acad Sci. 1999; 878:290-310. DOI: 10.1111/j.1749-6632.1999.tb07691.x. View

14.

Payne J, Stoner J, Nummikoski P, Reinhardt R, Goren A, Wolff M . Subantimicrobial dose doxycycline effects on alveolar bone loss in post-menopausal women. J Clin Periodontol. 2007; 34(9):776-87. PMC: 2174266. DOI: 10.1111/j.1600-051X.2007.01115.x. View

15.

Preshaw P . Host response modulation in periodontics. Periodontol 2000. 2008; 48:92-110. DOI: 10.1111/j.1600-0757.2008.00252.x. View

16.

Cunha-Cruz J, Hujoel P, Maupome G, Saver B . Systemic antibiotics and tooth loss in periodontal disease. J Dent Res. 2008; 87(9):871-6. PMC: 2577017. DOI: 10.1177/154405910808700916. View

17.

Tenenbaum H, Shelemay A, Girard B, Zohar R, Fritz P . Bisphosphonates and periodontics: potential applications for regulation of bone mass in the periodontium and other therapeutic/diagnostic uses. J Periodontol. 2002; 73(7):813-22. DOI: 10.1902/jop.2002.73.7.813. View

18.

Van Dyke T . The management of inflammation in periodontal disease. J Periodontol. 2008; 79(8 Suppl):1601-8. PMC: 2563957. DOI: 10.1902/jop.2008.080173. View

19.

Pedrazzoni M, Alfano F, Girasole G, Giuliani N, Fantuzzi M, Gatti C . Clinical observations with a new specific assay for bone alkaline phosphatase: a cross-sectional study in osteoporotic and pagetic subjects and a longitudinal evaluation of the response to ovariectomy, estrogens, and bisphosphonates. Calcif Tissue Int. 1996; 59(5):334-8. DOI: 10.1007/s002239900136. View

20.

Golub L, Lee H, Stoner J, Sorsa T, Reinhardt R, Wolff M . Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women. J Periodontol. 2008; 79(8):1409-18. PMC: 2553351. DOI: 10.1902/jop.2008.070623. View